Cargando...
Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical models
We show that variability in general levels of drug sensitivity in pre-clinical cancer models confounds biomarker discovery. However, using a very large panel of cell lines, each treated with many drugs, we could estimate a general level of sensitivity to all drugs in each cell line. By conditioning...
Gardado en:
| Publicado en: | Genome Biol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5031330/ https://ncbi.nlm.nih.gov/pubmed/27654937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13059-016-1050-9 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|